放射線腫瘍学市場：製品、技術、用途、エンドユーザー別-2024-2030年の世界予測

放射線腫瘍学市場規模は2023年に135億9,000万米ドルと推計され、2024年には145億6,000万米ドルに達し、CAGR 7.28%で2030年には222億3,000万米ドルに達すると予測されています。

放射線腫瘍学は、がん治療における電離放射線の使用に焦点を当てています。放射線を正確に照射することで、がん細胞を標的として除去したり、その発生を抑制したりします。放射線療法はがん治療の重要な要素であり、単独療法として、または化学療法や他の治療法と組み合わせて使用することができます。放射線腫瘍学は、技術の進歩や治療技術とともに絶えず進化しており、より精密で効果的ながん治療を可能にしています。放射線腫瘍学市場の成長要因としては、世界のがん罹患率の増加、放射線治療技術の進歩、非侵襲的治療法に対する需要の高まりなどが挙げられます。しかし、放射線療法や関連機器に関連する高額な費用、熟練した専門家の不足が、同市場にとって大きな課題となっています。がん治療における研究開発への政府企業や投資の増加、治療の安全性を向上させる放射線腫瘍学治療の進歩が、放射線腫瘍学市場に有利な機会を生み出しています。

製品放射線腫瘍学ハードウェアの大幅な普及

放射線腫瘍学のハードウェアには、放射線療法によるがん治療に使用される物理的な装置や機械が含まれます。主なハードウェア製品には、線形加速器（リニアック）、陽子線治療システム、CT、MRI、PETスキャナーなどの放射線治療機器に組み込まれる画像装置が含まれます。これらの機器は、周囲の健康な組織への被ばくを最小限に抑えながら、腫瘍部位に正確な線量の放射線を照射するために不可欠です。放射線腫瘍学のサービスには、効率的なシステム運用、患者ケア、臨床結果に必要なさまざまなサポートが含まれます。これには、腫瘍学用ハードウェアの設置、保守、修理、医療専門家に対するトレーニング、治療計画に関するコンサルティングサービス、放射線治療施設の運営管理などが含まれます。さらに、ワークフローの最適化と患者ケアの向上を保証する高度な治療計画サポート、線量測定サービス、患者サポートプログラムも含まれます。放射線腫瘍学ソフトウェアは、臨床医が効果的な治療計画を立案し提供するために不可欠です。このソフトウェア・カテゴリーには、治療計画システム（TPS）、記録・検証システム、線量管理プラットフォーム、データ分析ツールが含まれます。現代の治療計画システムは、複雑な線量計算、線量分布の3D可視化、腫瘍を正確に狙うための画像ソフトとの統合を可能にする洗練されたツールです。さらに、腫瘍学情報システム（OIS）は、患者情報とワークフローを管理するために不可欠なものです。

技術である：健康な組織への被曝を最小限に抑え、患者の転帰を改善するための外部照射療法の活用

外部照射療法は、体外から腫瘍を狙い撃ちする高エネルギービームを利用する、がん治療の主要な治療法です。EBRTの先端技術は、精度を高め、健常組織への被曝を最小限に抑え、患者の予後を改善することを目的としています。コンパクトな先進放射線治療システムは、従来の選択肢よりもスペース効率が高く、資源集約的でないように設計されたEBRTのカテゴリーを代表します。サイバーナイフシステムは非侵襲的な放射線治療の選択肢であり、ロボットアームを使用して高度に集束された放射線ビームを照射します。このシステムの精度は高く、体のあらゆる部分の腫瘍をミリメートル以下の精度で治療することができます。ガンマナイフ技術は、脳疾患の治療を目的とした定位放射線手術（SRS）です。トモセラピーは、強度変調放射線治療（IMRT）をコンピュータ断層撮影（CT）画像と統合し、正確な治療を行うものです。線形加速器は現代の放射線治療の基礎であり、さまざまながんを治療するために高エネルギーのX線や電子線を発生させる。陽子線治療は、X線ではなく陽子を使用する放射線治療の発展形です。サイクロトロンは陽子線治療に使われる粒子加速器で、陽子線を高エネルギーに加速してから患者の体内に照射します。シンクロトロンは陽子線治療で使用される粒子加速器のもう一つの形式です。サイクロトロンよりもさらに高いエネルギーまで陽子を加速することができ、根深い腫瘍の治療に不可欠です。内部ビーム放射線療法は、放射性物質を腫瘍の内部またはごく近くに設置する治療法です。アプリケーターは、放射性線源を保持し、治療部位に正確に配置するために設計された装置です。子宮頸部、前立腺、乳房、皮膚など、特定の解剖学的部位に合わせてさまざまな形や大きさのものがあります。アフターローダーは、すでに患者に装着されているアプリケーターに放射性線源を送り込む高度な機械です。電子ブラキセラピーは、放射性同位元素の代わりに小型化されたX線源が放射線を照射するブラキセラピーの一形態です。シードは、ブラキセラピー、特に前立腺がんに使用される小さな放射性ペレットです。全身放射線療法は放射性同位元素療法とも呼ばれ、放射性薬剤を使用し、血流にのってがん細胞を殺傷します。

応用：乳がん治療における放射線腫瘍学の重要性

リンパ腫や特定の白血病などの特定の種類の血液がんに対しては、がん細胞を破壊するため、またはリンパ節腫大や腫瘍による症状を緩和するために放射線療法を行うことができます。放射線は、がん細胞が集中している身体の特定の部位に照射されることがあり、これは関与照射として知られています。また、幹細胞移植の前に、コンディショニングレジメンの一部として使用されることもあります。放射線療法は、乳房温存手術（乳腺腫瘤摘出術）後の乳がんの治療において、再発のリスクを低減するために用いられます。また、腫瘍が大きい場合やがんがリンパ節に転移している場合には、乳房切除術後に適用されることもあります。さらに、強度変調放射線治療（IMRT）などの高度な技術により、高精度の標的照射が可能になり、周囲の健康な組織へのダメージを最小限に抑えることができます。胃、結腸、直腸、膵臓などの消化器がんには放射線療法が必要です。例えば直腸がんでは、化学療法と組み合わせた術前放射線療法が、腫瘍を小さくして外科的切除をしやすくするための標準です。限局性および進行性の前立腺がんでは、放射線療法が重要な役割を果たします。早期の前立腺がんに対しては、外照射やブラキセラピーによる一次治療として用いられます。また、骨や他の臓器に転移したがんを標的にすることもあり、症状の緩和や治療成績の向上をもたらします。肺がんの治療では、定位体放射線療法（SBRT）を含む放射線腫瘍学技術が、手術の適応とならない患者の腫瘍細胞を破壊するための非常に効果的で非侵襲的な選択肢を提供します。さらに、放射線療法は手術の補助として、あるいは局所進行例や転移例において化学療法と併用することで、症状の緩和や生存期間の延長を図ることができます。放射線療法は、非黒色腫皮膚がん、特に腫瘍が大きすぎたり、深すぎたり、手術による治療が困難な部位に存在したりする場合の貴重な治療法です。特に、皮膚を透過しない電子線治療が有用です。メラノーマの場合、放射線は一次治療にはならないが、転移の治療や外科的切除後の補助療法として使用されることがあります。

エンドユーザー：総合的ながん治療を提供する病院部門における放射線腫瘍学の潜在的使用法

放射線療法を提供する病院は通常、包括的ながん治療を提供する大規模施設です。外科的処置、化学療法、リハビリテーションサービス、放射線治療など、総合的な医療サービスが提供されるため、患者は病院を好むことが多いです。集学的アプローチを必要とする複雑ながん治療では、病院を好む傾向が強くなります。独立した放射線治療センターは、放射線治療サービスのみに特化した専門施設です。これらのセンターは、よりアクセスしやすく、より早く治療を開始できる治療法を求める患者に好まれています。さらに、患者の体験は病院での治療よりも個別化されていることが多いです。

地域別の洞察

放射線腫瘍学市場は、高いヘルスケア支出、先進的なヘルスケアインフラ、技術革新の強固なパイプラインにより、南北アメリカで成長しています。高齢化率の上昇、がん罹患率の上昇、確立された償還制度により、同地域では放射線治療へのアクセスが容易になっています。欧州連合（EU）では、施設が分散しており、腫瘍学の研究開発への関心が高まっていることから、KEYWORDサービスに対する需要が高いです。中東・アフリカの放射線腫瘍学市場は、ヘルスケアインフラへの投資拡大、先端技術の採用増加、新世代機器を調達するがん治療施設の新設などの影響を受けています。ヘルスケアインフラへの政府投資と、現地での機器製造に重点を置くがん罹患率の上昇が、APAC地域における放射線腫瘍学市場の著しい成長を示しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは放射線腫瘍学市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、放射線腫瘍学市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.放射線腫瘍学市場の市場規模および予測は？

2.放射線腫瘍学市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.放射線腫瘍学市場の技術動向と規制枠組みは？

4.放射線腫瘍学市場における主要ベンダーの市場シェアは？

5.放射線腫瘍学市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんの蔓延と放射線治療の導入の増加
    • 低侵襲手術への関心の高まり
    • がん治療への認知とアクセスを広めるための政府の取り組み
  • 抑制要因
    • 放射線治療機器に関連する高コスト
  • 機会
    • 放射線治療機器の技術的進歩
    • 放射線腫瘍学治療の研究開発への継続的な非政府投資
  • 課題
    • 訓練を受けた放射線腫瘍学専門家の不足と、厳格な規制遵守および承認
• 市場セグメンテーション分析
  • 製品：放射線腫瘍学ハードウェアの大幅な普及
  • 技術：外部放射線療法を利用して健康な組織への被ばくを最小限に抑え、患者の転帰を改善する
  • 応用：乳がん治療における放射線腫瘍学の重視
  • エンドユーザー：総合的ながん治療を提供するための病院部門における放射線腫瘍学の潜在的な使用
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 放射線腫瘍学市場：製品別

• ハードウェア
• サービス
• ソフトウェア

第7章 放射線腫瘍学市場：技術別

• 外部放射線治療
• 内部放射線治療

第8章 放射線腫瘍学市場：用途別

• 血液がん
• 乳がん
• 消化器がん
• 前立腺がん
• 呼吸器および肺がん
• 皮膚ガン

第9章 放射線腫瘍学市場：エンドユーザー別

• 病院
• 独立放射線治療センター

第10章 南北アメリカの放射線腫瘍学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の放射線腫瘍学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの放射線腫瘍学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • シーメンスヘルシナーズ、Aspektを買収し放射線腫瘍学サービスを強化
  • フレッド・ハッチの新しい放射線腫瘍学部門が形を成す
  • GEヘルスケアが放射線治療用の新ソリューションを発表
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. RADIATION ONCOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. RADIATION ONCOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. RADIATION ONCOLOGY MARKET DYNAMICS
• FIGURE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. RADIATION ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. RADIATION ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RADIATION ONCOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL RADIATION ONCOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYBERKNIFE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GAMMA KNIFE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TOMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY TOMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINEAR ACCELERATORS (LINAC), BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY LINEAR ACCELERATORS (LINAC), BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYCLOTRON, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY CYCLOTRON, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYNCHROTRON, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYNCHROTRON, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATORS & AFTER LOADERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATORS & AFTER LOADERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ELECTRONIC BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY ELECTRONIC BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SEEDS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SEEDS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYSTEMIC BEAM RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SYSTEMIC BEAM RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BLOOD CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY & LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY RESPIRATORY & LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL RADIATION ONCOLOGY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 83. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 84. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 85. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 86. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 87. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 88. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 89. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 90. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 91. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 94. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 95. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 96. AMERICAS RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 97. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 98. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 99. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 100. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 101. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 102. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 103. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 104. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 105. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 106. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 107. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 108. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 109. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 110. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 111. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 114. ARGENTINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 115. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 116. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 117. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 118. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 119. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 120. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 121. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 122. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 123. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 124. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 125. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 126. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 127. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 128. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 129. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 132. BRAZIL RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 133. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. CANADA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 136. CANADA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 137. CANADA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 138. CANADA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 139. CANADA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 140. CANADA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 141. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 142. CANADA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 143. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 144. CANADA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 145. CANADA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 146. CANADA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 147. CANADA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. CANADA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. CANADA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. CANADA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 152. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 153. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 154. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 155. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 156. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 157. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 158. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 159. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 160. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 161. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 162. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 163. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 164. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 165. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. MEXICO RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 172. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 173. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 174. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 175. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 176. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 177. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 178. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 179. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 180. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 181. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 182. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 183. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 188. UNITED STATES RADIATION ONCOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 189. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 190. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 191. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 192. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 193. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 194. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 195. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 196. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 197. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 198. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 199. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 200. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 201. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 202. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 203. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 206. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 207. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 208. ASIA-PACIFIC RADIATION ONCOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 209. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 212. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 213. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 214. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 215. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 216. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 217. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 218. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 219. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 220. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 221. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 222. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 223. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. AUSTRALIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. CHINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 230. CHINA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 231. CHINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 232. CHINA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 233. CHINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 234. CHINA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 235. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 236. CHINA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 237. CHINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 238. CHINA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 239. CHINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 240. CHINA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 241. CHINA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. CHINA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. CHINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 244. CHINA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 245. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. INDIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 248. INDIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 249. INDIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 250. INDIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 251. INDIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 252. INDIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 253. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 254. INDIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 255. INDIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 256. INDIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 257. INDIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 258. INDIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 259. INDIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. INDIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. INDIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 262. INDIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 263. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 264. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 265. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 266. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 267. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 268. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 269. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 270. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 271. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 272. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 273. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 274. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 275. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 276. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 277. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 278. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 279. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 280. INDONESIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 281. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 282. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 283. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 284. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 285. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 286. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 287. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 288. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 289. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 290. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 291. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 292. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 293. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 294. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 295. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 296. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 297. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. JAPAN RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 302. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 303. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 304. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 305. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 306. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 307. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 308. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 309. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 310. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 311. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 312. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
• TABLE 313. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 314. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 315. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 316. MALAYSIA RADIATION ONCOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 317. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 318. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 319. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 320. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 321. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 322. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 323. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 324. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY COMPACT ADVANCED RADIOTHERAPY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 325. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2018-2023 (USD MILLION)
• TABLE 326. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY PROTON THERAPY, 2024-2030 (USD MILLION)
• TABLE 327. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2018-2023 (USD MILLION)
• TABLE 328. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY INTERNAL BEAM RADIATION THERAPY, 2024-2030 (USD MILLION)
• TABLE 329. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
• TABLE 330. PHILIPPINES RADIATION ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, 2024-20

[191 Pages Report] The Radiation Oncology Market size was estimated at USD 13.59 billion in 2023 and expected to reach USD 14.56 billion in 2024, at a CAGR 7.28% to reach USD 22.23 billion by 2030.

Radiation oncology focuses on the use of ionizing radiation in the treatment of cancer. It involves the precise delivery of radiation to target and eliminate cancer cells or inhibit their development. Radiation therapy is a critical element of cancer treatment and can be used as a standalone therapy or in combination with chemotherapy and other therapeutic modalities. Radiation oncology continually evolves with technological advancements and treatment techniques, allowing for more precise and effective cancer care. Factors contributing to the growth of the radiation oncology market include the increasing global prevalence of cancer, advancements in radiation therapy technologies, and the rising demand for non-invasive treatment modalities. However, the high costs associated with radiation therapy and related instruments and a lack of skilled professionals pose a significant challenge to the market. Rising government enterprises and investments in R&D in the treatment of cancer treatments and advances in radiation oncology treatment to improve treatment safety create a lucrative opportunity for the radiation oncology market.

Product: Significant penetration of radiation oncology hardware

Radiation oncology hardware encompasses the physical devices and machines used to treat cancer through radiation therapy. Key hardware products include linear accelerators (LINACs), proton therapy systems, and imaging devices incorporated into radiotherapy equipment such as CT, MRI, and PET scanners. This equipment is integral in delivering precise doses of radiation to tumor sites while minimizing exposure to surrounding healthy tissues. Services in radiation oncology involve the spectrum of support required for efficient system operation, patient care, and clinical outcomes. This includes installation, maintenance, and repair of oncology hardware; training for medical professionals; consultation services for treatment planning; and operational management of radiation therapy facilities. Additionally, services may also encompass advanced treatment planning support, dosimetry services, and patient support programs that ensure optimized workflows and enhanced patient care. Radiation oncology software is crucial for clinicians to design and deliver effective treatment plans. This software category includes treatment planning systems (TPS), record and verify systems, dose management platforms, and data analytics tools. Contemporary treatment planning systems are sophisticated tools that allow for the intricacies of dosimetric calculation, 3D visualization of dose distribution, and integration with imaging software to target tumors precisely. Furthermore, oncology information systems (OIS) are essential for managing patient information and workflow in a radiation oncology department.

Technology: Utilization of external beam radiation therapy to minimize exposure to healthy tissues and improve patient outcomes

External beam radiation therapy is a principal modality for treating cancer, utilizing high-energy beams to target tumors from outside the body. Advanced technologies in EBRT aim to enhance precision, minimize exposure to healthy tissues, and improve patient outcomes. Compact advanced radiotherapy systems represent a category of EBRT designed to be space-efficient and less resource-intensive than traditional options. The CyberKnife system is a non-invasive option for radiotherapy that uses a robotic arm to deliver highly focused radiation beams. The system's precision allows for treating tumors in any portion of the body with sub-millimeter accuracy. Gamma knife technology is a stereotactic radiosurgery (SRS) designed to treat brain disorders. Tomotherapy integrates intensity-modulated radiation therapy (IMRT) with computed tomography (CT) imaging for precise treatment delivery. Linear accelerators are the cornerstone of modern radiation therapy, producing high-energy X-rays or electrons for treating various cancers. Proton therapy is an evolved state of radiation treatment that uses protons rather than X-rays. A cyclotron is a particle accelerator used in proton therapy that accelerates protons to high energies before they are directed into the patient's body. Synchrotrons are another form of particle accelerator utilized in proton therapy. They can accelerate protons to even higher energies than cyclotrons, essential for treating deep-seated tumors. Internal beam radiation therapy is a procedure that involves placing radioactive material inside or very close to the tumor. Applicators are devices designed to hold radioactive sources and position them precisely at the treatment site. They come in various shapes and sizes, tailored to the specific anatomical site, such as the cervix, prostate, breast, or skin. Afterloaders are sophisticated machines that deliver the radioactive source into the applicator already placed in the patient. Electronic brachytherapy is a form of brachytherapy where a miniaturized X-ray source delivers radiation instead of radioactive isotopes. Seeds are tiny radioactive pellets used in brachytherapy, particularly for prostate cancer. Systemic radiation therapy also referred to as radioisotope therapy, involves the use of radioactive drugs, or radiopharmaceuticals, which travel through the bloodstream to target and kill cancer cells.

Application: Significant emphasis on radiation oncology for breast cancer treatment

For certain types of blood cancer, such as lymphomas or specific leukemias, radiation therapy can be used to destroy cancer cells or to alleviate symptoms caused by enlarged lymph nodes or tumors. Radiation may be directed to specific areas of the body with a concentration of cancer cells, which is known as involved field radiation, or it can be used as part of a conditioning regimen before a stem cell transplant. Radiation therapy is used in the treatment of breast cancer after breast-conserving surgery (lumpectomy) to reduce the risk of recurrence. It may also be applied after mastectomy in cases with larger tumors or when cancer has spread to lymph nodes. Additionally, advanced techniques such as intensity-modulated radiation therapy (IMRT) allow high-precision targeting, minimizing damage to surrounding healthy tissues. Gastrointestinal cancers, including those of the stomach, colon, rectum, and pancreas, require radiation therapy. In rectal cancer, for example, preoperative radiation combined with chemotherapy is the standard to reduce tumor size, making it more amenable to surgical removal. Radiation therapy plays a key role in localized and advanced prostate cancer. For early-stage prostate cancer, it can be used as a primary treatment through external beam radiation or brachytherapy. It may also target cancer that has spread to the bones or other organs, providing symptom relief and improving the treatment outcome. In the treatment of lung cancer, radiation oncology techniques, including stereotactic body radiation therapy (SBRT), offer a highly effective, non-invasive option for destroying tumor cells in patients that may not be candidates for surgery. Additionally, radiation may be employed as an adjunct to surgery or combined with chemotherapy in locally advanced or metastatic cases to alleviate symptoms and extend survival. Radiation therapy serves as a valuable treatment for non-melanoma skin cancers, particularly for tumors that are too large, too deep, or located in areas difficult to treat with surgery. Electron beam therapy, which does not penetrate beyond the skin, is particularly useful. For melanomas, radiation may not be a primary treatment; however, it can be used to treat metastases or as adjuvant therapy after surgical removal of the cancer.

End-User: Potential use of radiation oncology in hospital sectors to provide comprehensive cancer care

Hospitals offering radiation therapy are typically large-scale facilities that provide comprehensive cancer care. Patients often prefer hospitals due to the integrated medical services they offer, which could include surgical procedures, chemotherapy, rehabilitation services, and radiotherapy. The preference for hospitals is heightened in complex cancer treatments requiring a multidisciplinary approach. Independent radiotherapy centers are specialized facilities dedicated solely to providing radiotherapy services. These centers are preferred by patients seeking treatment options that are more accessible and may offer a quicker initiation of therapy. Additionally, the patient experience is often more personalized than in hospital settings.

Regional Insights

The radiation oncology market is growing in the Americas due to high healthcare expenditure, advanced healthcare infrastructure, and a robust pipeline of technological innovations. The rising aging population, rising cancer prevalence, and a well-established reimbursement system facilitate access to radiation therapy in the region. The European Union exhibits a strong demand for radiation oncology services with a well-distributed network of facilities and a growing interest in oncology research and development. The Middle East and Africa's radiation oncology market is influenced by growing investment in healthcare infrastructure, an increasing adoption of advanced technologies, and the establishment of new cancer treatment facilities procuring new-generation equipment. Governmental investments in healthcare infrastructure and a rising incidence of cancer emphasis on local equipment manufacturing demonstrate significant growth of the radiation oncology market in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Radiation Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiation Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Radiation Oncology Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Becton, Dickinson and Company, Bionix LLC, BrainLab AG, Canon Inc., Carl Zeiss AG, Curium SAS, Eckert and Ziegler AG, Elekta AB, GE HealthCare Technologies Inc., Hitachi, LTD., Hologic, Inc., IntraOp Medical, Inc., Ion Beam Applications S.A., Isoray Inc., Koninklijke Philips N.V., Nordion Inc., Optivus Proton Therapy, Inc., P-Cure LTD., Panacea Medical Technologies Pvt. LTD., Provision Healthcare, LLC., Stryker Corporation, Sumitomo Heavy Industries, LTD, Theragenics Corporation, Varian Medical Systems by Siemens Healthineers, and ViewRay, Inc..

Market Segmentation & Coverage

This research report categorizes the Radiation Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Hardware
  • Services
  • Software

• Technology
  • External Beam Radiation Therapy
    • Compact advanced radiotherapy systems
      • Cyberknife
      • Gamma Knife
      • Tomotherapy

• Linear Accelerators (Linac)
• Proton Therapy
  • Cyclotron
  • Synchrotron
• Internal Beam Radiation Therapy
  • Brachytherapy
    • Applicators & After loaders
    • Electronic Brachytherapy
    • Seeds

• Systemic Beam Radiation Therapy
• Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory & Lung Cancer
  • Skin Cancer

• End-User
  • Hospitals
  • Independent Radiotherapy Centers

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Radiation Oncology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiation Oncology Market?

3. What are the technology trends and regulatory frameworks in the Radiation Oncology Market?

4. What is the market share of the leading vendors in the Radiation Oncology Market?

5. Which modes and strategic moves are suitable for entering the Radiation Oncology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cancer and increasing adoption of radiation procedures
    • 5.1.1.2. Rising preference for minimally invasive procedures
    • 5.1.1.3. Government initiatives to spread awareness and accessibility to cancer treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with radiotherapy equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in radiation therapy equipment
    • 5.1.3.2. Ongoing non-government investments in R&D of radiation oncology treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of trained radiation oncology professionals coupled with stringed regulatory compliances and approvals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significant penetration of radiation oncology hardware
  • 5.2.2. Technology: Utilization of external beam radiation therapy to minimize exposure to healthy tissues and improve patient outcomes
  • 5.2.3. Application: Significant emphasis on radiation oncology for breast cancer treatment
  • 5.2.4. End-User: Potential use of radiation oncology in hospital sectors to provide comprehensive cancer care
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Radiation Oncology Market, by Product

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
• 6.4. Software

7. Radiation Oncology Market, by Technology

• 7.1. Introduction
• 7.2. External Beam Radiation Therapy
• 7.3. Internal Beam Radiation Therapy

8. Radiation Oncology Market, by Application

• 8.1. Introduction
• 8.2. Blood Cancer
• 8.3. Breast Cancer
• 8.4. Gastrointestinal Cancer
• 8.5. Prostate Cancer
• 8.6. Respiratory & Lung Cancer
• 8.7. Skin Cancer

9. Radiation Oncology Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Independent Radiotherapy Centers

10. Americas Radiation Oncology Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Radiation Oncology Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Radiation Oncology Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Siemens Healthineers Buys Aspekt to Bolster Radiation Oncology Services
  • 13.3.2. Fred Hutch's New Radiation Oncology Division Takes Shape
  • 13.3.3. GE HealthCare Launches New Solutions for Radiation Therapy
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio